期刊文献+

^(131)I治疗后甲减患者血清降钙素及降钙素储备功能变化 被引量:4

Changes of the serum calcitonin level and Calcitonin reserve function in patients with hypothyroidism after ^(131)I therapy
下载PDF
导出
摘要 目的研究经131I治疗后出现甲减患者血清降钙素水平以及降钙素储备功能的变化。方法选取在我科就诊的年龄为21~40岁经131I治疗后并发甲减的甲亢患者及部分经131I治疗的甲状腺非髓样癌患者,分别按性别、甲减发生时间分组。以21~40岁正常人为对照组,分别测定各组血清降钙素水平及降钙素储备功能。结果女性早发甲减组CT基础值为(10.78±3.00)mmol/L,5min降钙素峰值为(17.84±4.94)mmol/L,升高幅度为(7.06±4.14)mmol/L,与对照组差异有统计学意义(P值均为0.00)。女性迟发甲减组CT基础值为(11.28±3.10)mmol/L,降钙素峰值为(17.82±4.02)mmol/L,升高幅度为(6.01±4.07)mmol/L,与对照组差异有统计学意义(P值均为0.00)。女性早发组与迟发组差异无统计学意义(P值分别为0.646、0.879、0.438)。甲癌组降钙素基础值、峰值、升高幅度与对照组差异有统计学意义(P值均为0.00)。男性甲减组CT基础值为(11.98±3.93)mmol/L,降钙素峰值为(17.68±3.42)mmol/L,升高幅度为(5.50±3.33)mmol/L,与对照组差异有统计学意义(P值均为0.00)。结论 131I治疗后甲减患者血清降钙素水平及降钙素储备功能均降低。 Objective To study the changes of the serum calcitonin level and calcitonin reserve capacity in patients with hypothyroidism after 131↑I therapy.Methods The subjects singled out in my treatment were divided into groups by both gender and time of hypothyroidism-occurrence.These patients,at the age of 21-40 years,were with hyperthyroidism secondary hypothyroidism or thyroid cancer after the treatment by 131↑I.Some health person at the age of 21-40 years were taken as the control group.Then the serum calcitonin levels and calcitonin reserve function of each group were measured at variational times.Results In the group of women with early-onset hypothyroidism the CT basal value was(10.78±3.00) mmol/L,the mean value of peak calcitonin was(17.84± 4.94) mmol/L,the mean value of the creased range was(7.06± 4.14) mmol/L,were with significant difference compared to the control group(P=0.00,0.00,0.00) and with no significant difference compared to the late-onset group.In the group of women with late-onset hypothyroidism the CT basal value,the mean value of peak calcitonin and the mean value of the creased range were with significant difference compared to the control group(P=0.00,0.00,0.00).In the thyroid cancer group,there was significant difference compared to the control group in the CT basal value,the mean value of peak calcitonin and the mean creased range(P=0.00,0.00,0.00).In the group of men with hypothyroidism the CT basal value was(11.98±3.93) mmol/L,the mean value of peak calcitonin was(17.68±3.42) mmol/L,the mean value of the increased range was(5.50±3.33) mmol/L,were with significant difference compared to the control group(P=0.00).Conclusion The serum calcitonin levels and calcitonin reserve function were decreased in patients of hypothyroidism after 131↑I therapy.
出处 《海南医学》 CAS 2011年第16期11-13,共3页 Hainan Medical Journal
关键词 ~131I 降钙素 降钙素储备功能 甲状腺功能减低 131↑I Calcitonin Calcitonin reserve function Hypothyroidism
  • 相关文献

参考文献9

  • 1司宏伟,李险峰.^(131)I对甲状腺细胞凋亡的影响[J].国外医学(放射医学核医学分册),2003,27(2):94-96. 被引量:6
  • 2徐健,刘小立,杨雪锋,李兰英,孙云,孙秀发.过量碘对甲状腺细胞凋亡的影响[J].卫生研究,2007,36(4):443-445. 被引量:14
  • 3Turgut B, Babul A, Ozdemir O, et al. Evaluation of the cell death pathway and apoptosis-stunning effect relationship after low- and high-dose ^131I adrninistra- tions in rat thyroid tissue [J]. Cancer Bio- ther Radiopharm, 2006, 21(4): 342-351.
  • 4Tzanela M, Thalassinos NC, Nikou A, et al. Effect of ^131I treatment on the calcitonin response to calcium infusion in hyperthyroid pa- tients [J]. Clin Endocrinol (Oxf), 1993, 38(1): 25-28.
  • 5Bayraktar M, Gedik O, Akalin S, et al. The effect of radioactive io- dine treatment on thyroid C cells [J]. Clin Endocrinol (Oxf), 1990, 33(5): 625-630.
  • 6Body JJ, Demeester-Mirkine N, Corvilain J. Calcitonin deficiency after radioactive iodine treatment [J]. Ann Intern Med, 1988, 109 (7): 590-591.
  • 7刘薇,叶志明,柴瑞敏,于湄,杨丽萍.原发性甲状腺机能减退患者骨代谢状况及其影响因素分析[J].临床荟萃,2005,20(17):983-984. 被引量:1
  • 8赵辉,徐晓红,禹晖.Graves’病^(131)I治疗剂量及甲低与TGA、TMA的关系[J].放射免疫学杂志,2007,20(1):11-13. 被引量:4
  • 9Borges MF, Abelin NM, Menezes FO, et al. Calcitonin deficiency in early stages of chronic autoimmune thyroiditis [J]. Clin Endocrinol (Oxf), 1998, 49 (1): 69-75.

二级参考文献33

  • 1刘薇,柴瑞敏,王雪,叶志明,于湄.甲状腺机能减退对骨代谢影响的初步研究[J].中国骨质疏松杂志,1997,3(3):21-23. 被引量:2
  • 2聂秀玲,孙云,李兰英,阎玉芹,陈祖培.碘对大鼠体内及体外甲状腺钠碘转运体mRNA表达的调节[J].中国地方病学杂志,2005,24(6):625-627. 被引量:5
  • 3Palazzo FF, Hammond LJ, Mirakian R. Death of the autoimmune thyrocyte: Is it pushed or does it jump? [J]. Thyroid,2000, 10(7): 561-572.
  • 4Debatin KM. Role of CD95(APO-1/Fas) system in chemotherapy[A]. Hickman JA, Dive C (eds). Apoptosis and cancer chemotherapy[M]. New Jersey: Humana Press, 1999. 175-189.
  • 5Yin XM. Bid, a critical mediator for apoptosis induced by the activation of Fas / TNF-R, death receptors in hepatocytes [J]. J Mol Med, 2000, 78:203-211.
  • 6Davies TF. A new role for methimazole in autoimmune thyroid disease: inducing T cell apoptosis [J]. Thyroid, 2000, 10(7): 525-526.
  • 7Mitsiades N, Poulak V, Tseleni-Balafouta S, et al. Fas ligand express in thyroid follicular cells from patients with thionamide-treated Grave's disease [J]. Thyroid, 2000, 10(7):527-532.
  • 8Matola TD, Ascoli FD, Fenzi G, et al. Amiodarone induces cytochrome c release and apoptosis through an iodine independent mechanism [J]. J Clin Endocrinol Metab, 2000, 85(11): 4323-4330.
  • 9Kawakami A, Matsuoka N, Tsuboi M, et al. CD4^+ T cell-mediated cytotoxicity toward thyrocytes: The important of Fas/Fas ligand interaction inducing apoptosis of thyrocytes and the inhibitory effect of thyroid-stimulating hormone [J]. LabInvest, 2000, 80: 471-484.
  • 10Froehlich E, Wahl R. Effects of retinal on follicular procine thyrocytes in culture [J]. J Mol Med, 1999, 77: 189-192.

共引文献18

同被引文献45

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部